TCL Archive NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals February 16, 1990
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk. June 29, 2001
